Alzheimer%s Disease Global Clinical Trials Review, H2, 2012

• Publication date: July 2012
• Report size: 123 pages

Alzheimer's Disease Global Clinical Trials Review, H2, 2012 Summary GlobalData's clinical trial report, “Alzheimer’s Disease Global Clinical Trials Review, H2, 2012" provides data on the Alzheimer’s Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Alzheimer’s Disease. It includes an overview of the trial numbers and their recruitmen...

Alzheimer's Disease Global Clinical Trials Review, H2, 2012



Summary



GlobalData's clinical trial report, “Alzheimer’s Disease Global Clinical Trials Review, H2, 2012" provides data on the Alzheimer’s Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Alzheimer’s Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Alzheimer’s Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.



Scope


- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)



Reasons to buy


- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Global Drug Discovery And Development Industry

Table of Contents

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Alzheimer's Disease 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Alzheimer's Disease 24
Subjects Recruited Over a Period of Time 31
Prominent Sponsors 32
Top Companies Participating in Alzheimer's Disease Therapeutics Clinical Trials 34
Prominent Drug Comparison 36
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
Pfizer Inc. 37
Clinical Trial Overview of Pfizer Inc. 37
Johnson & Johnson 43
Clinical Trial Overview of Johnson & Johnson 43
AstraZeneca PLC 46
Clinical Trial Overview of AstraZeneca PLC 46
Eli Lilly and Company 49
Clinical Trial Overview of Eli Lilly and Company 49
Eisai Inc. 51
Clinical Trial Overview of Eisai Inc. 51
GlaxoSmithKline plc 53
Clinical Trial Overview of GlaxoSmithKline plc 53
Bristol-Myers Squibb Company 55
Clinical Trial Overview of Bristol-Myers Squibb Company 55
Merck & Co., Inc. 57
Clinical Trial Overview of Merck & Co., Inc. 57
Avid Radiopharmaceuticals, Inc. 58
Clinical Trial Overview of Avid Radiopharmaceuticals, Inc. 58
Novartis AG 59
Clinical Trial Overview of Novartis AG 59
Abbott Laboratories 63
Clinical Trial Overview of Abbott Laboratories 63
AFFiRiS AG 64
Clinical Trial Overview of AFFiRiS AG 64
Sanofi 65
Clinical Trial Overview of Sanofi 65
Medivation, Inc. 66
Clinical Trial Overview of Medivation, Inc. 66
Chiesi Farmaceutici SpA 67
Clinical Trial Overview of Chiesi Farmaceutici SpA 67
H. Lundbeck A/S 68
Clinical Trial Overview of H. Lundbeck A/S 68
Orion Corporation 69
Clinical Trial Overview of Orion Corporation 69
TauRx Therapeutics Ltd 70
Clinical Trial Overview of TauRx Therapeutics Ltd 70
Genentech, Inc. 71
Clinical Trial Overview of Genentech, Inc. 71
GE Healthcare 72
Clinical Trial Overview of GE Healthcare 72
Clinical Trial Overview of Top Universities / Institutes / Hospitals 73
Institute for Neurodegenerative Disorders 73
Clinical Trial Overview of Institute for Neurodegenerative Disorders 73
Centre Hospitalier Universitaire de Nice 75
Clinical Trial Overview of Centre Hospitalier Universitaire de Nice 75
University of Wisconsin Madison 76
Clinical Trial Overview of University of Wisconsin Madison 76
Assistance Publique - Hopitaux de Paris 77
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 77
University of Washington 78
Clinical Trial Overview of University of Washington 78
Oregon Health and Science University 79
Clinical Trial Overview of Oregon Health and Science University 79
University Hospital, Angers 80
Clinical Trial Overview of University Hospital, Angers 80
The University of Kansas 81
Clinical Trial Overview of The University of Kansas 81
Johns Hopkins University 82
Clinical Trial Overview of Johns Hopkins University 82
University Hospital, Bordeaux 83
Clinical Trial Overview of University Hospital, Bordeaux 83
University of California, Los Angeles 84
Clinical Trial Overview of University of California, Los Angeles 84
Mayo Clinic 85
Clinical Trial Overview of Mayo Clinic 85
University of Pittsburgh 86
Clinical Trial Overview of University of Pittsburgh 86
Queen's University 87
Clinical Trial Overview of Queen's University 87
Kyoto University 88
Clinical Trial Overview of Kyoto University 88
Sunnybrook Health Sciences Centre 89
Clinical Trial Overview of Sunnybrook Health Sciences Centre 89
McMaster University 90
Clinical Trial Overview of McMaster University 90
Thomas Jefferson University 91
Clinical Trial Overview of Thomas Jefferson University 91
Samsung Medical Center 92
Clinical Trial Overview of Samsung Medical Center 92
University of Sao Paulo 93
Clinical Trial Overview of University of Sao Paulo 93
Five Key Clinical Profiles 94
Appendix 120
Abbreviations 120
Definitions 120
Research Methodology 121
Secondary Research 121
About GlobalData 122
Contact Us 122
Disclaimer 122
Source 123

List of Tables

List of Tables
Alzheimer's Disease Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8
Alzheimer's Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Alzheimer's Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Alzheimer's Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11
Alzheimer's Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12
Alzheimer's Disease Therapeutics Clinical Trials, North America, Top Countries, 2012* 13
Alzheimer's Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 14
Alzheimer's Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 15
Alzheimer's Disease Therapeutics Clinical Trials, BRIC Countries, 2012* 16
Alzheimer's Disease Therapeutics Clinical Trials, G7 Countries, 2012* 17
Alzheimer's Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Alzheimer's Disease Therapeutics Clinical Trials, E7 Countries, 2012* 19
Alzheimer's Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Alzheimer's Disease Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21
Alzheimer's Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22
Alzheimer's Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Alzheimer's Disease Therapeutics Market, Global, Suspended Clinical Trials, 2012* 24
Alzheimer's Disease Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 25
Alzheimer's Disease Therapeutics Market, Global, Terminated Clinical Trials, 2012* 26
Alzheimer's Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 31
Alzheimer's Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 33
Alzheimer's Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 35
Alzheimer's Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 36
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 37
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012* 43
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 46
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 49
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012* 51
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 53
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012* 55
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 57
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Avid Radiopharmaceuticals, Inc., 2012* 58
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 59
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012* 63
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by AFFiRiS AG, 2012* 64
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 65
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Medivation, Inc., 2012* 66
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiesi Farmaceutici SpA, 2012* 67
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lundbeck A/S, 2012* 68
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Orion Corporation, 2012* 69
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by TauRx Therapeutics Ltd, 2012* 70
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Genentech, Inc., 2012* 71
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by GE Healthcare, 2012* 72
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute for Neurodegenerative Disorders, 2012* 73
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Nice, 2012* 75
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2012* 76
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012* 77
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2012* 78
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2012* 79
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Angers, 2012* 80
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Kansas, 2012* 81
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2012* 82
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Bordeaux, 2012* 83
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2012* 84
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 85
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012* 86
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2012* 87
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2012* 88
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Sunnybrook Health Sciences Centre, 2012* 89
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by McMaster University, 2012* 90
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2012* 91
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2012* 92
Alzheimer's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2012* 93

List of Figures

List of Figures
Alzheimer's Disease Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8
Alzheimer's Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Alzheimer's Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Alzheimer's Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11
Alzheimer's Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12
Alzheimer's Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 13
Alzheimer's Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 14
Alzheimer's Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 15
Alzheimer's Disease Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16
Alzheimer's Disease Therapeutics Clinical Trials, G7 Countries (%), 2012* 17
Alzheimer's Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Alzheimer's Disease Therapeutics Clinical Trials, E7 Countries (%), 2012* 19
Alzheimer's Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Alzheimer's Disease Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21
Alzheimer's Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22
Alzheimer's Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Alzheimer's Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 31
Alzheimer's Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 32
Alzheimer's Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 34
Alzheimer's Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 36
GlobalData Methodology 121

Companies Mentioned